TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vitrolife AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
314,195
|
316,510
|
290,610 |
| Financial expenses |
11,666
|
12,797
|
10,693 |
| Earnings before taxes |
58,678
|
-334,535
|
48,255 |
| EBITDA |
98,463
|
100,667
|
94,354 |
| Total assets |
1,518,826
|
1,471,611
|
1,846,733 |
| Current assets |
205,197
|
172,495
|
141,351 |
| Current liabilities |
61,289
|
50,198
|
55,804 |
| Equity capital |
1,187,481
|
1,146,539
|
1,503,913 |
| - share capital |
2,438
|
2,523
|
2,516 |
| Employees (average) |
1,082
|
1,084
|
1,117 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
78.2%
|
77.9%
|
81.4% |
| Turnover per employee |
290
|
292
|
260 |
| Profit as a percentage of turnover |
18.7%
|
-105.7%
|
16.6% |
| Return on assets (ROA) |
4.6%
|
-21.9%
|
3.2% |
| Current ratio |
334.8%
|
343.6%
|
253.3% |
| Return on equity (ROE) |
4.9%
|
-29.2%
|
3.2% |
| Change turnover |
8,445
|
25,054
|
139,572 |
| Change turnover % |
3%
|
9%
|
92% |
| Chg. No. of employees |
-2
|
-33
|
639 |
| Chg. No. of employees % |
0%
|
-3%
|
134% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.